I. Introduction
===============

Blood loss during orthognathic surgery can be excessive, especially in multiple jaw surgeries. The use of a local anesthetic in conjunction with a vasoconstrictor is the most effective means of reducing blood loss in these procedures. Epinephrine is the most commonly used vasoconstrictor[@B1][@B2][@B3]. This drug not only provides hemostasis, but also improves the depth and duration of anesthesia along with a reduction of systemic toxic effects in local infiltration anesthesia[@B2]. The hemodynamic effects of intravenous epinephrine infusion are well known and include elevations in heart rate (HR) and blood pressure (BP). During local infiltration anesthesia, even small doses of epinephrine can produce cardiovascular effects. These hemodynamic changes were observed following a submucosal injection of lidocaine containing 54 µg epinephrine; higher doses of epinephrine produced a greater hemodynamic response[@B3]. Previous studies have reported that hemodynamic changes were caused by the submucosal infiltration of epinephrine during surgery performed under general anesthesia. In addition to these hemodynamic effects, epinephrine also influences metabolism, including the stimulation of lipolysis and an increase in lactate and glucose levels[@B4].

Hyperlactatemia has a wide spectrum of manifestations. Patients can present with fatigue or gastrointestinal complaints, such as abdominal pain, nausea, vomiting, or diarrhea. Severe lactic acidosis can have a more severe presentation, such as hypotension, altered mental status, dyspnea, and cardiac arrhythmias[@B5]. However, the development of lactic acidosis in patients receiving epinephrine for local infiltration anesthesia or vasoconstriction is seldom recognized clinically. Only one case study concerning significant glycogenolysis, lactic acidosis, and hypokalemia as well as hemodynamic changes in patients undergoing a cervical cone biopsy under epidural anesthesia was found in the literature[@B6].

There have been no reports concerning lactic acidosis induced by the submucosal injection or application of epinephrine as a vasoconstrictor in young, healthy patients undergoing orthognathic surgery under general anesthesia with serial follow-up of the perioperative lactate level. Therefore, we present such two cases.

II. Cases Report
================

1. Case 1
---------

A 25-year-old, 63-kg male patient was scheduled to undergo Le Fort I osteotomy, bilateral sagittal split osteotomy (BSSO), and genioplasty for the correction of mandibular prognathism with midface deficiency. A tonsillectomy had been performed in the same patient 10 years previously under general anesthesia without incident. His medical history was unremarkable. At the time of surgery, he was taking no medications and reported no allergies. The preanesthetic evaluation findings were all within normal limits.

The patient was not premedicated, and his preanesthetic vital signs were BP of 135/80 mmHg, HR of 87 beats per minute (bpm), and pulse oxygen saturation (SpO~2~) of 99%. General anesthesia was induced with intravenous thiopental sodium (300 mg), 2% lidocaine (60 mg), rocuronium (50 mg), and remifentanil (0.15 µg/kg/min), and a tracheal tube was inserted nasotracheally. General anesthesia was maintained with sevoflurane (1.5-3.0 vol%), O~2~ (1.5 L/min), N~2~O (1.5 L/min), and remifentanil (0.05-0.15 µg/kg/min). After performing a modified Allen\'s test to assess the collateral blood flow to the hand, a left radial artery catheter was inserted to maintain continuous arterial pressure monitoring and arterial blood gas sampling. Following induction, the patient\' s arterial blood gas analysis (ABGA) results were pH 7.47, PaO~2~ 324 mmHg, PaCO~2~ 40 mmHg, HCO~3~^--^ 29.1 mEq/L, base excess (BE) 5.4 mEq/L, glucose 102 mg/dL, lactate 1 mmol/L, and normal electrolytes.

A submucosal injection of 2% lidocaine with 1:100,000 epinephrine was administered into the upper vestibular area for local infiltration anesthesia before the first surgical incision was made. During the operation, additional injections were administered in both the retromolar area and in the lower anterior vestibule before each surgical incision. In total, 18 mL of 2% lidocaine with 1:100,000 epinephrine (180 µg epinephrine) were administered submucosally. Additionally, gauze soaked in 25 mL of 0.01% epinephrine was used for dense packing on the operative site, which exhibited frequent bleeding. The packing had to be left in place for 5 to 10 minutes until the bleeding stopped. During most of the procedure, the patient\'s vital signs were BP of 115-148 mmHg/45-65 mmHg and HR of 82-110 bpm. However, BP and HR increased to 155-185 mmHg/65-85 mmHg and 115-120 bpm, respectively, after intermittent injections of lidocaine containing 1:100,000 epinephrine. At this time, a calcium channel blocker, an ultra-short-acting β-blocker, and an increase in the remifentanil infusion were applied to correct his vital signs.

One hour twenty minutes after the first incision, the ABGA revealed the following: pH 7.29, PaCO~2~ 43 mmHg, PaO~2~ 288 mmHg, HCO~3~^--^ 20.7 mEq/L, BE --5.9 mEq/L, glucose 274 mg/dL, and lactate 7.7 mmol/L. These results indicated metabolic acidosis, hyperglycemia, and hyperlactatemia, which became more severe over time. According to the serial ABGA measurements obtained during the operation, the minimal pH was 7.19, the HCO~3~^--^ and BE decreased to 17.6 mEq/L and --10.6 mEq/L, respectively, and the glucose and lactate increased to 338 mg/dL and 11.6 mmol/L. The surgery concluded uneventfully. The patient was transferred to the intensive care unit (ICU) in a sedated and intubated state. Postoperatively, the serial ABGA findings improved, returning to normal 13 hours after the end of the surgery with fluid administration.([Table 1](#T1){ref-type="table"}) He was extubated 21 hours after surgery end and discharged from the hospital without any problems.

2. Case 2
---------

A 25-year-old, 60-kg male patient was scheduled to undergo high Le Fort I osteotomy, BSSO, genioplasty, and malar augmentation for a mandibular prognathism with midface deficiency. His medical history was unremarkable except for a history of pneumonia two years previous. The patient was taking no medications and reported no allergies. The preanesthetic evaluation findings were all normal.

He was not premedicated, and his preanesthetic vital signs were BP of 128/70 mmHg, HR of 98 bpm, and SpO~2~ of 99%. General anesthesia was induced with intravenous thiopental sodium (300 mg), 2% lidocaine (60 mg), rocuronium (50 mg), and remifentanil (0.15 µg/kg/min), and nasotracheal intubation was performed. General anesthesia was maintained with sevoflurane (1.5-2.5 vol%), O~2~ (1.5 L/min), N~2~O (1.5 L/min), and remifentanil (0.05-0.13 µg/kg/min). After radial artery catheterization, the patient\'s first ABGA results were pH 7.44, PaO~2~ 350 mmHg, PaCO~2~ 37 mmHg, HCO~3~^--^ 25.1 mEq/L, BE 0.9 mEq/L, glucose 95 mg/dL, lactate 1.6 mmol/L, and normal electrolytes.

Submucosal infiltration of 2% lidocaine with 1:100,000 epinephrine was performed in the upper vestibular area before the first surgical incision. During the operation, an additional injection was administered in the lower vestibule before each surgical incision. In all, 18 mL of 2% lidocaine along with 1:100,000 epinephrine (180 µg epinephrine) were injected submucosally. In addition, gauze soaked with 25 mL of 0.01% epinephrine was used for dense packing at the bleeding site in the operative field until the bleeding stopped. Intraoperatively, the patient\'s vital signs were BP of 105-140 mmHg/50-70 mmHg and HR of 95-110 bpm. However, the patient\'s BP and HR increased to 160-170 mmHg/65-100 mmHg and 105-128 bpm, respectively, after intermittent injections of lidocaine containing 1:100,000 epinephrine. To maintain stable vital signs, a calcium channel blocker and dose increases of remifentanil were applied.

One hour after the first incision, the ABGA was pH 7.3, PaCO~2~ 43 mmHg, PaO~2~ 296 mmHg, HCO~3~^--^ 21.2 mEq/L, BE --5.2 mEq/L, glucose 277 mg/dL, and lactate 5.3 mmol/L. These findings implied the presence of lactic acidosis and hyperglycemia. After the first hour, ABGA measurements were repeated at one-hour intervals during the procedure. The ABGA results worsened over time, showing maximum change three hours after the surgery began. The pH, HCO~3~^--^, and BE decreased to pH 7.29, 18.3 mEq/L, and --8.3 mEq/L, respectively, while the glucose and lactate increased to 331 mg/dL and 9.9 mmol/L. The surgery was successful, and the patient was transferred to the ICU in a sedated and intubated state. Serial ABGA findings subsequently improved dramatically and returned to normal two hours after the end of the surgery with fluid resuscitation.([Table 2](#T2){ref-type="table"}) He was extubated 19 hours after surgery end and discharged from the hospital with no complications.

III. Discussion
===============

In orthognathic surgery, local anesthetic solutions containing epinephrine are routinely administered submucosally in the operative field. Epinephrine is the main vasoconstrictor used in dental practice today[@B1][@B2][@B3]. In commonly used dental cartridges, the concentration of epinephrine varies from 1:50,000 (20 µg/mL) to 1:200,000 (5 µg/mL)[@B2]. Epinephrine delays the absorption of local anesthetics, which have vasodilating properties and rapid diffusing action. It also controls bleeding at incision sites and produces preemptive analgesia[@B1][@B2][@B3][@B7].

This vasoconstriction is due to the α-adrenergic receptor activation of epinephrine on peripheral blood vessels, most notably under the skin and within the mucous membranes. However, it also activates cardiac β~1~-adrenergic receptors, which increase the HR, BP, contractility, and myocardial oxygen consumption, and skeletal muscle β~2~-adrenergic receptors, leading to vasodilation of blood vessels[@B2][@B3].

The metabolic effects of epinephrine include insulin resistance, hyperglycemia, hyperlactatemia, and the stimulation of lipolysis. Epinephrine directly induces lipolysis and increases the concentration of free fatty acids. Inhibition by epinephrine of glycogen synthesis in the skeletal muscle and liver likely accounts for this hyperglycemia and insulin resistance[@B4][@B6]. In addition, the development of hyperlactatemia is associated with hyperglycemia and pyruvate generation in the presence of pyruvate dehydrogenase inhibition. This mechanism is attributed to the epinephrine effect because β~2~-adrenergic receptors stimulate aerobic glycolysis through Na-K-ATPase activation in skeletal muscle. The associated enhanced glycolysis promotes pyruvate generation; pyruvate is later converted to lactate[@B4][@B8][@B9].

The sedation induced by general anesthesia and remifentanil infusion has the advantage of suppressing the plasma epinephrine, norepinephrine, and hemodynamic responses to surgical stress. However, concomitant administration of a local anesthetic containing epinephrine negates these advantages. The sumucosal infiltration of epinephrine in orthognathic surgery significantly elevates the plasma epinephrine concentration due to the exogenous epinephrine rather than an adrenal release produced by the surgical stress[@B10]. In addition, submucosal injections of lidocaine, which contains epinephrine, are rapidly absorbed into the blood during general anesthesia, producing a higher plasma concentration than observed during conscious conditions[@B7]. Therefore, although elevating the plasma epinephrine is not identical to increasing sympathetic tone[@B10], we assumed that the elevated plasma epinephrine level induced by the submucosal infiltration of epinephrine during surgery directly stimulated the hemodynamic and metabolic changes in these cases. In addition, the topical application of epinephrine-soaked gauze to the mucosa can induce the absorption of epinephrine into the systemic circulation and produce the observed hemodynamic effects[@B11]. Thus, it seems that a significant amount of epinephrine was absorbed via the submucosal injections and topical applications in these cases.

Lactic acidosis (lactate \>5 mmol/L and pH \<7.35) is classified as either type A or type B. Type A lactic acidosis is produced in response to a hypoxic or hypoperfusion state. In the absence of oxygen, pyruvate dehydrogenase is inhibited, preventing the conversion of pyruvate to acetyl-CoA and forcing pyruvate to undergo an anaerobic metabolism and be converted into lactate. In contrast, type B lactic acidosis is generated in the absence of hypoxia or hypoperfusion. Pyruvate is converted to lactate by way of aerobic glycolysis. The common causes of type B lactic acidosis are drugs, malignancies, and inborn errors of metabolism[@B8][@B9].

The patients in these cases were young and healthy, and they had not received any other drug commonly recognized as a cause of lactic acidosis prior to the surgery. Their liver and kidney functions were normal, and there was no evidence of global hypoxia or hypoperfusion during the perioperative management. The patients had no factors that could have caused lactic acidosis except epinephrine; the lactic acidosis resolved spontaneously within hours after the cessation of epinephrine infiltration. Therefore, epinephrine-induced lactate released from the skeletal muscle and mediated by β~2~-adrenergic receptors may be a prime mechanism underlying lactic acidosis. It is known that the benign, self-limiting type B acidosis almost never causes a lactate level greater than 10 mmol/L[@B9]. Our patients developed elevated lactate levels that did not exceed 11.6 mmol/L and 9.9 mmol/L, respectively. However, regional hypoxia or hypoperfusion may not be detectable using systemic parameters alone. Future studies should investigate whether depressed mucosal blood flow or peripheral vasoconstriction induced by epinephrine in the operative field can produce lactic acidosis in patients undergoing orthognathic surgery under general anesthesia.

Higher concentrations of epinephrine may provide better hemostasis when infiltrated directly into the operative field[@B3]. Unfortunately, this practice also increases the likelihood of systemic effects of epinephrine in a dose-dependent manner[@B10]. There has been much debate about the maximum recommended dose of epinephrine as a local anesthetic. In 1984, the American Dental Association recommended 200 µg as the maximum dose for healthy patients[@B12]. High doses can produce detrimental effects, especially in patients with significant cardiovascular disease; therefore, the maximum recommended dose of epinephrine for cardiac patients is 40 µg[@B2][@B3][@B10][@B13]. Additionally, if concerns exist regarding the systemic effects of epinephrine, the following methods can reduce the risk of adverse events: minimize the administration of epinephrine when possible, closely monitor the patient\'s vital signs, carefully administer the drug using preliminary aspiration to avoid inadvertent intravascular injection, and readminister additional doses with subsequent monitoring of vital signs if the patient\'s vital signs are stable[@B2][@B3][@B13]. In general, most systemic effects of epinephrine are observed within 5 to 10 minutes of its injection, and the action duration of systemic epinephrine is approximately 10 to 15 minutes[@B2][@B3]. Therefore, careful observation for hemodynamic and metabolic changes in patients is essential during this period. In addition, the activity of drug-metabolizing enzymes tends to be reduced at low core temperatures. Accordingly, it is important to maintain a normothermic state when using a high dose of epinephrine.

The use of sodium bicarbonate to correct lactic acidosis remains controversial because sodium bicarbonate can increase lactate production[@B14]. Recent studies have suggested that therapy be guided by changes in lactate level[@B15]. Resuscitative efforts should be complemented to treat any underlying causes of lactic acidosis[@B16]. Our two patients were in healthy condition with unremarkable medical history, and we assumed the cause of lactic acidosis was excessive epinephrine use. Therefore, we only observed the patients with careful monitoring of their vital signs and fluid administration.

In conclusion, these cases suggest that the submucosal injection of a submaximal dose of a lidocaine containing epinephrine along with the topical application of epinephrinesoaked gauze applied directly to the mucosa can induce significant metabolic effects, such as lactic acidosis and hyperglycemia, as well as hemodynamic effects, including hypertension and tachycardia, which resolve rapidly without additional treatment following surgery in healthy patients undergoing orthognathic surgery with general anesthesia. Although these effects are unlikely to be serious in healthy patients, local anesthetics containing epinephrine should be used with caution, especially in patients with cardiovascular diseases, acid-base abnormalities, and disorders that could lead to hyperlactatemia or hyperglycemia. Furthermore, careful observation for changes in plasma lactate and glucose levels through serial follow-up of ABGA along with the intensive monitoring of vital signs should be performed in the perioperative period if epinephrine was used excessively as a vasoconstrictor during surgery. At the same time, deliberate hypotensive anesthesia (systolic BP remaining below 100 mmHg or mean arterial pressure \[MAP\] 30% below a patient\'s baseline MAP with a minimum MAP of 50-65 mmHg) could be an alternative to reduce the use of epinephrine as a vasoconstrictor and the loss of blood during surgery.
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###### Serial arterial blood gas analysis during and after anesthesia in Case 1
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  Parameter            Post-induction   OP 1 hr 20 min   OP 2 hr 20 min   OP 3 hr 40 min   Post OP 2 hr   Post OP 13 hr
  -------------------- ---------------- ---------------- ---------------- ---------------- -------------- ---------------
  FiO~2~               0.5              0.5              0.5              0.5              0.3            0.24
  pH                   7.47             7.29             7.24             7.19             7.31           7.41
  PaO~2~ (mmHg)        324              288              285              181              146            122
  PaCO~2~ (mmHg)       40               43               43               44               41             44
  HCO~3~^--^ (mEq/L)   29.1             20.7             18.4             17.6             20.6           27.9
  BE (mEq/L)           5.4              --5.9            --9              --10.6           --5.7          3.3
  Na (mmol/L)          139              140              144              146              144            138
  K (mmol/L)           3.2              2.3              2.4              3                3.8            3.7
  Ca^2+^ (mmol/L)      1.1              1.06             1.03             1.02             0.96           1.08
  Glucose (mg/dL)      102              274              324              338              240            144
  Lactate (mmol/L)     1                7.7              11.6             11.4             3.7            1.6
  SaO~2~ (%)           100              100              100              99               99             99

(BE: base excess, OP 1 hr 20 min: 1 hour 20 minutes after operation start, OP 2 hr 20 min: 2 hours 20 minutes after operation start, OP 3 hr 40 min: 3 hours 40 minutes after operation start, Post OP 2 hr: 2 hours after the end of the operation, Post OP 13 hr: 13 hours after the end of the operation)

###### Serial arterial blood gas analysis during and after anesthesia in Case 2
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  Parameter            Post-induction   OP 1 hr   OP 2 hr   OP 3 hr   OP 4 hr   Post OP 30 min   Post OP 2 hr
  -------------------- ---------------- --------- --------- --------- --------- ---------------- --------------
  FiO~2~               0.5              0.5       0.5       0.5       0.5       0.35             0.35
  pH                   7.44             7.3       7.28      7.29      7.34      7.35             7.36
  PaO~2~ (mmHg)        350              296       279       288       278       210              176
  PaCO~2~ (mmHg)       37               43        40        38        36        42               49
  HCO~3~^--^ (mEq/L)   25.1             21.2      18.8      18.3      19.4      23.2             27.7
  BE (mEq/L)           0.9              --5.2     --7.9     --8.3     --6.4     --2.4            2.3
  Na (mmol/L)          137              139       138       140       142       139              138
  K (mmol/L)           3.4              2.5       3         2.8       3.3       3.6              3.8
  Ca^2+^ (mmol/L)      1.07             1.03      0.97      1.03      1.04      1.05             1.09
  Glucose (mg/dL)      95               277       300       331       203       133              82
  Lactate (mmol/L)     1.6              5.3       7.9       9.9       7.7       4.7              0.9
  SaO~2~ (%)           100              100       100       100       100       100              100

(BE: base excess, OP 1 hr: 1 hour after operation start, OP 2 hr: 2 hours after operation start, OP 3 hr: 3 hours after operation start, OP 4 hr: 4 hours after operation start, Post OP 30 min: 30 minutes after the end of the operation, Post OP 2 hr: 2 hours after the operation\'s end)
